The impact of beta blockers on survival outcomes in non-small cell lung cancer patients treated with immune checkpoint inhibitors

被引：0

作者：

Oh, Michael ^{[1
]}

Guzner, Alex ^{[1
]}

Wainwright, Derek ^{[1
]}

Mohindra, Nisha ^{[1
]}

Chae, Young Kwang ^{[1
]}

Behdad, Amir ^{[1
]}

Villaflor, Victoria ^{[1
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P635

引用

页数：1

共 50 条

[31] Association between peripheral eosinophils and clinical outcomes in patients with non-small cell lung cancer treated with immune checkpoint inhibitors
Okauchi, Shinichiro
Shiozawa, Toshihiro
Miyazaki, Kunihiko
Nishino, Kengo
Sasatani, Yuika
Ohara, Gen
Kagohashi, Katsunori
Sato, Shinya
Kodama, Takahide
Satoh, Hiroaki
Hizawa, Nobuyuki
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (02): : 152 - 160
[32] Impact of Body Mass Index on Clinical Outcomes of Immune Checkpoint Blockers in Advanced Non-Small Cell Lung Cancer
Kulkarni, A.
Zhang, S.
De For, T.
Patel, M.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S275 - S276
[33] Impact of pseudoprogression and treatment beyond progression on outcome in patients with non-small cell lung cancer treated with immune checkpoint inhibitors
Won, Sang Eun
Park, Hyo Jung
Byun, Sangil
Pyo, Junhee
Kim, Jwa Hoon
Choi, Chang-Min
Lee, Jae Cheol
Lee, Dae Ho
Kim, Sang-We
Yoon, Shinkyo
Kim, Kyung Won
ONCOIMMUNOLOGY, 2020, 9 (01):
[34] Impact of Brain Metastases in Immune Checkpoint Inhibitors (ICI) Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
Hendriks, L.
Henon, C.
Auclin, E.
Mezquita, L.
Ferrara, R.
Audigier-Valette, C.
Mazieres, J.
Lefebyre, C.
Le Moulec, S.
Cousin, S.
Duchemann, B.
Le Pechoux, C.
Botticella, A.
Ammari, S.
Gazzah, A.
Caramella, C.
Adam, J.
Planchard, D.
De Ruysscher, D.
Dingemans, A.
Besse, B.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S384 - S384
[35] Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitors
Takamori, Shinkichi
Takada, Kazuki
Shimokawa, Mototsugu
Jinnnouchi, Mikako
Matsubara, Taichi
Haratake, Naoki
Miura, Naoko
Toyozawa, Ryo
Yamaguchi, Masafumi
Takenoyama, Mitsuhiro
Yoneshima, Yasuto
Tanaka, Kentaro
Okamoto, Isamu
Tagawa, Tetsuzo
Mori, Masaki
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (06) : 1745 - 1753
[36] Predictive impact of sarcopenia in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A retrospective study
Feng, Ying
Wang, Liyu
Zhu, Fan
Shi, Jianming
Wang, Yan
Zhang, Yingru
Chen, Xiaofeng
Zhang, Luyao
HELIYON, 2024, 10 (05)
[37] Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitors
Shinkichi Takamori
Kazuki Takada
Mototsugu Shimokawa
Mikako Jinnnouchi
Taichi Matsubara
Naoki Haratake
Naoko Miura
Ryo Toyozawa
Masafumi Yamaguchi
Mitsuhiro Takenoyama
Yasuto Yoneshima
Kentaro Tanaka
Isamu Okamoto
Tetsuzo Tagawa
Masaki Mori
Cancer Immunology, Immunotherapy, 2021, 70 : 1745 - 1753
[38] Impact of Steroid Use for Immune Related Adverse Events on Outcomes in Non-Small Cell Lung Cancer (NSCLC) Treated with Checkpoint Inhibitors
Shah, N.
Kelly, W.
Ma, B.
Puthiamadathil, J.
Serzan, M.
Zhou, Y.
Tan, M.
Subramaniam, D.
Giaccone, G.
Liu, S.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2147 - S2147
[39] Neoadjuvant Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
Xue, Chongxiang
Dong, Huijing
Chen, Ying
Lu, Xingyu
Zheng, Shuyue
Cui, Huijuan
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (06): : 779 - 788
[40] Highlights on immune checkpoint inhibitors in non-small cell lung cancer
Shen, Meng
Ren, Xiubao
TUMOR BIOLOGY, 2017, 39 (03)

← 1 2 3 4 5 →